These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21560107)

  • 21. EUS in the evaluation of esophageal carcinoma.
    Mallery S; Van Dam J
    Gastrointest Endosc; 2000 Dec; 52(6 Suppl):S6-11. PubMed ID: 11115941
    [No Abstract]   [Full Text] [Related]  

  • 22. For localized gastroesophageal cancer, you give chemoradiation before surgery, but then what happens?
    Ajani JA; Correa AM; Swisher SG; Wu TT
    J Clin Oncol; 2007 Sep; 25(27):4315-6. PubMed ID: 17878485
    [No Abstract]   [Full Text] [Related]  

  • 23. [Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies].
    Yun HW; Shim KN
    Korean J Gastroenterol; 2013 Jun; 61(6):303-6. PubMed ID: 23877209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of FDG-PET/CT in follow-up of patients treated with resective gastric surgery for tumour.
    Graziosi L; Bugiantella W; Cavazzoni E; Cantarella F; Porcari M; Baffa N; Donini A
    Ann Ital Chir; 2011; 82(2):125-9. PubMed ID: 21682102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of positron emission tomography in the (re-)staging of oesophageal cancer.
    Westerterp M; Van Westreenen HL; Sloof GW; Plukker JT; Van Lanschot JJ
    Scand J Gastroenterol Suppl; 2006; (243):116-22. PubMed ID: 16782630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection.
    Rizk N; Downey RJ; Akhurst T; Gonen M; Bains MS; Larson S; Rusch V
    Ann Thorac Surg; 2006 Mar; 81(3):1076-81. PubMed ID: 16488726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endoscopic therapy of esophago-gastric tumors.
    Lambert R
    Endoscopy; 1992; 24(1-2):24-33. PubMed ID: 1373114
    [No Abstract]   [Full Text] [Related]  

  • 28. Staging of adenocarcinoma of the gastroesophageal junction.
    Parry K; Haverkamp L; Bruijnen RC; Siersema PD; Offerhaus GJ; Ruurda JP; van Hillegersberg R
    Eur J Surg Oncol; 2016 Mar; 42(3):400-6. PubMed ID: 26777127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.
    Ott K; Weber WA; Lordick F; Becker K; Busch R; Herrmann K; Wieder H; Fink U; Schwaiger M; Siewert JR
    J Clin Oncol; 2006 Oct; 24(29):4692-8. PubMed ID: 16966684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The multidisciplinary team meeting improves staging accuracy and treatment selection for gastro-esophageal cancer.
    Davies AR; Deans DA; Penman I; Plevris JN; Fletcher J; Wall L; Phillips H; Gilmour H; Patel D; de Beaux A; Paterson-Brown S
    Dis Esophagus; 2006; 19(6):496-503. PubMed ID: 17069595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.
    Swisher SG; Erasmus J; Maish M; Correa AM; Macapinlac H; Ajani JA; Cox JD; Komaki RR; Hong D; Lee HK; Putnam JB; Rice DC; Smythe WR; Thai L; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Cancer; 2004 Oct; 101(8):1776-85. PubMed ID: 15386332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimodal imaging of esophagus and cardia cancer before and after treatment.
    Fiore D; Baggio V; Ruol A; Bocus P; Casara D; Corti L; Muzzio PC
    Radiol Med; 2006 Sep; 111(6):804-17. PubMed ID: 16896560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CT assessment of operability in carcinoma of the oesophagogastric junction.
    Terrier F; Schapira C; Fuchs WA
    Eur J Radiol; 1984 May; 4(2):114-7. PubMed ID: 6734608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging upper gastrointestinal malignancy.
    Iyer R; Dubrow R
    Semin Roentgenol; 2006 Apr; 41(2):105-12. PubMed ID: 16697889
    [No Abstract]   [Full Text] [Related]  

  • 35. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
    Swisher SG; Maish M; Erasmus JJ; Correa AM; Ajani JA; Bresalier R; Komaki R; Macapinlac H; Munden RF; Putnam JB; Rice D; Smythe WR; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Ann Thorac Surg; 2004 Oct; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
    Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
    Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indications and Limitations in the Management Algorithm of Patients With Esophageal Adenocarcinoma: Positron Emission Tomography Computed Tomography.
    Fisichella PM
    JAMA Surg; 2015 Jun; 150(6):562. PubMed ID: 25902411
    [No Abstract]   [Full Text] [Related]  

  • 38. Radiologic staging of gastrointestinal neoplasms.
    Mauro MA; Lee JK; Heiken JP; Balfe DM
    Surg Clin North Am; 1984 Feb; 64(1):67-85. PubMed ID: 6701731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Staging in Esophageal and Gastric Cancers.
    Hayes T; Smyth E; Riddell A; Allum W
    Hematol Oncol Clin North Am; 2017 Jun; 31(3):427-440. PubMed ID: 28501085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis and management of gastro-esophageal junction tumor].
    Chevallay M; Jung M; Niclauss N; Morel P; Mönig S
    Rev Med Suisse; 2017 Jun; 13(567):1236-1239. PubMed ID: 28643978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.